<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Rev Bras Ter Intensiva</journal-id>
      <journal-id journal-id-type="iso-abbrev">Rev Bras Ter Intensiva</journal-id>
      <journal-title-group>
        <journal-title>Revista Brasileira de Terapia Intensiva</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0103-507X</issn>
      <issn pub-type="epub">1982-4335</issn>
      <publisher>
        <publisher-name>Associa&#xE7;&#xE3;o Brasileira de Medicina
intensiva</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25607273</article-id>
      <article-id pub-id-type="pmc">4304472</article-id>
      <article-id pub-id-type="doi">10.5935/0103-507X.20140064</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Is this septic shock? A rare case of distributive shock</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Ser&#xE1; choque s&#xE9;ptico? Um caso raro de choque
distributivo</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Val-Flores</surname>
            <given-names>Luis Silva</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fior</surname>
            <given-names>Alberto</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Santos</surname>
            <given-names>Ana</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Reis</surname>
            <given-names>Lu&#xED;s</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bento</surname>
            <given-names>Lu&#xED;s</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label>Servi&#xE7;o de Medicina, Centro Hospitalar Oeste, Hospital Caldas da
Rainha - Caldas da Rainha, Portugal.</aff>
      <aff id="aff02"><label>2</label>Servi&#xE7;o de Medicina 1.2, Centro Hospitalar Lisboa Central,
Hospital S&#xE3;o Jos&#xE9; - Lisboa, Portugal.</aff>
      <aff id="aff03"><label>3</label>Unidade de Urg&#xEA;ncia M&#xE9;dica, Centro Hospitalar Lisboa
Central, Hospital S&#xE3;o Jos&#xE9; - Lisboa, Portugal.</aff>
      <author-notes>
        <corresp id="c01"><bold>Corresponding author:</bold> Luis Silva Val-Flores, Rua
Di&#xE1;rio de Not&#xED;cias, Hospital Distrital de Caldas da Rainha, 2500 -
Caldas da Rainha, Portugal. E-mail: <email>luisvalflores@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Oct-Dec</season>
        <year>2014</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Oct-Dec</season>
        <year>2014</year>
      </pub-date>
      <volume>26</volume>
      <issue>4</issue>
      <fpage>416</fpage>
      <lpage>420</lpage>
      <history>
        <date date-type="received">
          <day>05</day>
          <month>8</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>10</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>The authors report a rare case of shock in a patient without significant clinical
history, admitted to the intensive care unit for suspected septic shock. The patient
was initially treated with fluid therapy without improvement. A hypothesis of
systemic capillary leak syndrome was postulated following the confirmation of severe
hypoalbuminemia, hypotension, and hemoconcentration - a combination of three symptoms
typical of the disease. The authors discussed the differential diagnosis and also
conducted a review of the diagnosis and treatment of the disease.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>Os autores apresentam um caso raro de choque em doente sem antecedentes pessoais
significativos, admitido na unidade de terapia intensiva por suspeita de choque
s&#xE9;ptico. Inicialmente, foi tratado com fluidoterapia sem melhoria, tendo sido
aventada a hip&#xF3;tese de s&#xED;ndrome de hiperpermeabilidade capilar,
ap&#xF3;s confirma&#xE7;&#xE3;o de hipoalbulinemia paradoxal grave,
hipotens&#xE3;o e hemoconcentra&#xE7;&#xE3;o exuberante - tr&#xED;ade
caracter&#xED;stica da doen&#xE7;a. Os autores discutiram o diagn&#xF3;stico
diferencial e ainda realizaram uma revis&#xE3;o do diagn&#xF3;stico e do
tratamento da doen&#xE7;a.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Capillary permeability</kwd>
        <kwd>Hypotension</kwd>
        <kwd>Shock, septic</kwd>
        <kwd>Hemoconcentration</kwd>
        <kwd>Edema</kwd>
        <kwd>Case reports</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Systemic capillary leak syndrome (SCLK), also known as Clarkson&#x2019;s disease, was first
described in 1960.<sup>(<xref rid="r01" ref-type="bibr">1</xref>)</sup> The authors
described the case of a patient with recurrent episodes of distributive shock and
generalized edema, resulting from the passage of fluid and proteins from the
intravascular space into the extravascular space.<sup>(<xref rid="r01" ref-type="bibr">1</xref>)</sup></p>
      <p>Few reports are available in the literature, with an approximate total of 150 published
cases.<sup>(<xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r03" ref-type="bibr">3</xref>)</sup> SCLK may be fatal in extreme situations, when there is
no treatment or measures to reverse shock.</p>
      <p>The pathophysiology of this syndrome is associated with vascular endothelial
dysfunction, allowing the passage of fluids and macromolecules from the vascular space
into the interstitium.<sup>(<xref rid="r04" ref-type="bibr">4</xref>)</sup> That
alteration results in the depletion of fluid and therefore in a state of tissue
hypoperfusion and hypoxia characteristic of shock. Cellular elements remain in the
vascular territory, resulting in elevated leukocyte, erythrocyte, and platelet
counts.<sup>(<xref rid="r04" ref-type="bibr">4</xref>)</sup></p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 53-year-old Caucasian woman with a history of hypercholesterolemia, tobacco smoking,
and degenerative spinal disease, treated with clopidogrel, rosuvastatin, and ethyl
loflazepate began to develop symptoms of asthenia and generalized edema (feet, forearms,
and face) five months before admission. Hypothyroidism was diagnosed following
observation and brief analytical assessment (8.67&#x3BC;g/mL thyroid stimulating hormone -
TSH, 0.20-4.20&#x3BC;g/mL reference values - RV), which improved with levothyroxine. A new
episode of sudden generalized edema, which culminated in syncope, occurred three months
later, with subsequent recovery. She was observed at the Emergency Room (ER) at that
time, wherein she received complementary diagnostic tests. The following results were
observed: 16.5g/dL hemoglobin (Hg), 16.500U/L leukocytosis, 0.21mg/dL C-reactive protein
(CRP; RV&lt;0.30mg/dL), renal failure with 1.6mg/dL creatinine (Cr), and leukocyturia
(<xref ref-type="table" rid="t01">Table 1</xref>). The patient was treated with
ciprofloxacin and reassessed at a later consultation, wherein normalization of blood
count and of renal function and protein electrophoresis with monoclonal peak in the
gamma-globulin region were observed.</p>
      <table-wrap id="t01" orientation="portrait" position="float">
        <label>Table 1</label>
        <caption>
          <p>Progression of analytical parameters during hospitalization</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="1" colspan="1">&#xA0;</th>
              <th align="center" rowspan="1" colspan="1">
                <bold>1<sup>st</sup> syncope</bold>
              </th>
              <th align="center" rowspan="1" colspan="1">
                <bold>Admission to the ER</bold>
              </th>
              <th align="center" rowspan="1" colspan="1">
                <bold>12 hours later</bold>
              </th>
              <th align="center" rowspan="1" colspan="1">
                <bold>Day 1</bold>
              </th>
              <th align="center" rowspan="1" colspan="1">
                <bold>Day 2</bold>
              </th>
              <th align="center" rowspan="1" colspan="1">
                <bold>Day 3</bold>
              </th>
              <th align="center" rowspan="1" colspan="1">
                <bold>Day 5</bold>
              </th>
              <th align="center" rowspan="1" colspan="1">
                <bold>Day 12</bold>
              </th>
              <th align="center" rowspan="1" colspan="1">
                <bold>Hospital discharge</bold>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">Hemoglobin (g/dL)</td>
              <td align="center" rowspan="1" colspan="1">16.5</td>
              <td align="center" rowspan="1" colspan="1">20.7</td>
              <td align="center" rowspan="1" colspan="1">18.1</td>
              <td align="center" rowspan="1" colspan="1">15.4</td>
              <td align="center" rowspan="1" colspan="1">12</td>
              <td align="center" rowspan="1" colspan="1">8.2</td>
              <td align="center" rowspan="1" colspan="1">7.8</td>
              <td align="center" rowspan="1" colspan="1">9.1</td>
              <td align="center" rowspan="1" colspan="1">9.8</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Hematocrit (%)</td>
              <td align="center" rowspan="1" colspan="1">48.1</td>
              <td align="center" rowspan="1" colspan="1">62.4</td>
              <td align="center" rowspan="1" colspan="1">54.4</td>
              <td align="center" rowspan="1" colspan="1">47</td>
              <td align="center" rowspan="1" colspan="1">35.8</td>
              <td align="center" rowspan="1" colspan="1">23.7</td>
              <td align="center" rowspan="1" colspan="1">23.0</td>
              <td align="center" rowspan="1" colspan="1">27.5</td>
              <td align="center" rowspan="1" colspan="1">30.3</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Leukocytes x 10<sup>9</sup>/L</td>
              <td align="center" rowspan="1" colspan="1">16.50</td>
              <td align="center" rowspan="1" colspan="1">25.40</td>
              <td align="center" rowspan="1" colspan="1">33.30</td>
              <td align="center" rowspan="1" colspan="1">43.80</td>
              <td align="center" rowspan="1" colspan="1">25.80</td>
              <td align="center" rowspan="1" colspan="1">10.50</td>
              <td align="center" rowspan="1" colspan="1">11.70</td>
              <td align="center" rowspan="1" colspan="1">16.00</td>
              <td align="center" rowspan="1" colspan="1">10.50</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Urea (mg/dL)</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">59</td>
              <td align="center" rowspan="1" colspan="1">54</td>
              <td align="center" rowspan="1" colspan="1">45</td>
              <td align="center" rowspan="1" colspan="1">32</td>
              <td align="center" rowspan="1" colspan="1">22</td>
              <td align="center" rowspan="1" colspan="1">85</td>
              <td align="center" rowspan="1" colspan="1">53</td>
              <td align="center" rowspan="1" colspan="1">67</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Creatinine (mg/dL)</td>
              <td align="center" rowspan="1" colspan="1">1.60</td>
              <td align="center" rowspan="1" colspan="1">1.54</td>
              <td align="center" rowspan="1" colspan="1">1.25</td>
              <td align="center" rowspan="1" colspan="1">1.27</td>
              <td align="center" rowspan="1" colspan="1">1.2</td>
              <td align="center" rowspan="1" colspan="1">0.89</td>
              <td align="center" rowspan="1" colspan="1">1.75</td>
              <td align="center" rowspan="1" colspan="1">1.01</td>
              <td align="center" rowspan="1" colspan="1">0.99</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Potassium (mEq/dL)</td>
              <td align="center" rowspan="1" colspan="1">4.6</td>
              <td align="center" rowspan="1" colspan="1">4.6</td>
              <td align="center" rowspan="1" colspan="1">4.3</td>
              <td align="center" rowspan="1" colspan="1">3.6</td>
              <td align="center" rowspan="1" colspan="1">3.5</td>
              <td align="center" rowspan="1" colspan="1">3.6</td>
              <td align="center" rowspan="1" colspan="1">3.9</td>
              <td align="center" rowspan="1" colspan="1">3.7</td>
              <td align="center" rowspan="1" colspan="1">4.1</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Calcium (mg/dL)</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">5.5</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">7.4</td>
              <td align="center" rowspan="1" colspan="1">8.7</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Total Proteins (g/dL)</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">2.73</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">3.72</td>
              <td align="center" rowspan="1" colspan="1">4.03</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Albumin (g/dL)</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">0.9</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">2.5</td>
              <td align="center" rowspan="1" colspan="1">3.2</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">3.6</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Creatine phosphokinase (U/L)</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">87</td>
              <td align="center" rowspan="1" colspan="1">129</td>
              <td align="center" rowspan="1" colspan="1">2.658</td>
              <td align="center" rowspan="1" colspan="1">8.406</td>
              <td align="center" rowspan="1" colspan="1">6.412</td>
              <td align="center" rowspan="1" colspan="1">3.176</td>
              <td align="center" rowspan="1" colspan="1">355</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Myoglobin</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
              <td align="center" rowspan="1" colspan="1">130</td>
              <td align="center" rowspan="1" colspan="1">&gt;4.026</td>
              <td align="center" rowspan="1" colspan="1">&gt;4.026</td>
              <td align="center" rowspan="1" colspan="1">3.080</td>
              <td align="center" rowspan="1" colspan="1">404.3</td>
              <td align="center" rowspan="1" colspan="1">39.9</td>
              <td align="center" rowspan="1" colspan="1">&#xA0;</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn>
            <p>ER - Emergency Room.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>A new episode of generalized edema, profuse sweating, and malaise, followed by syncope,
occurred on the day of admission. The ER assessment showed unmeasurable blood pressure,
preserved consciousness, no response to fluid therapy (3,000ml of crystalloid
administered), and oligo-anuria. The laboratory tests showed hemoconcentration (<xref ref-type="table" rid="t01">Table 1</xref>) (20.7g/dL Hb, 62.4% hematocrit - Htc and
25.400 leukocyte count) and acute renal failure (1.56mg/dL Cr) with metabolic acidemia
(50% FiO<sub>2</sub> blood gas analysis: 7.33 pH; 22.2 partial pressure of carbon
dioxide - pCO<sub>2</sub>; 130.3 partial pressure of oxygen - pO<sub>2</sub>; 11.5
bicarbonate - HCO<sub>3</sub>; 2.55 lactate; and 20 anion gap). The electrocardiogram
was negative for acute myocardial ischemia. The patient underwent
thoracic-abdominal-pelvic computed tomography with contrast, which excluded aortic
dissection, and she was transferred to the intensive care unit (ICU).</p>
      <p>The patient was anxious, sweaty, and with cold extremities at ICU admission. She was
also afebrile and had unmeasurable blood pressure, sinus tachycardia, and 98% oxygen
saturation with 50% Venturi mask. The cardiopulmonary auscultation was normal, the
abdomen was free from tenderness on pressure, and the lower extremities showed no edema.
Central venous pressure was 1cmH<sub>2</sub>O. The serum albumin level was 0.9g/dL (3.6
to 5.5g/dL RV) with 2.73g/dL total proteins (6.6 to 8.3g/dL RV).</p>
      <p>Given the severe hypoalbuminemia, blood pressure, and diuresis (70cc urine output in 10
hours) unresponsiveness to fluid resuscitation with crystalloids and worsening of
metabolic acidosis, 20% albumin replenishment and dialysis were started, reaching
hemodynamic stability and fluid and electrolyte balance. The transthoracic
echocardiogram showed a hyperdynamic left ventricular function with no further
alterations.</p>
      <p>The onset of severe lower limb edema, pain in the calf muscle region, and questionable
foot pulses by palpation occurred three hours after admission and fluid therapy with
crystalloids. The hypothesis of compartment syndrome was postulated and assessed by
vascular surgery and plastic surgery, and the need for decompression fasciotomy was
ruled out after performing Doppler ultrasound. Rhabdomyolysis with a creatine kinase
peak of 8406U/L was observed in the laboratory tests. Clinical improvement with
progressive decrease of leg perimeter and return of palpable pulses occurred 24 hours
later.</p>
      <p>On the 2<sup>nd</sup> day of hospitalization, the patient was orotracheally intubated
due to respiratory exhaustion associated with fluid overload and was mechanically
ventilated for 48 hours. On the 3<sup>rd</sup> day of hospitalization, diuresis resumed
with spontaneous negativation of water balance and gradual reduction of peripheral
edema, and dialysis was suspended on the 4<sup>th</sup> day. Hemoglobin levels were
normalized in the first hours of fluid therapy with progressive normalization of serum
albumin levels.</p>
      <p>Treatment with aminophylline was started upon suspected SCLK diagnosis. The patient was
transferred to the internal medicine ward on the 8<sup>th</sup> day of
hospitalization.</p>
      <p>The following results were obtained in the study and etiological assessment: normal
prothrombin and activated partial thromboplastin times, transaminases, normal gamma
glutamyl transferase, and alkaline phosphatase levels, 8mg/dL corrected calcium,
3.8mg/dL CRP (RV&lt;5.0). Urine II with 50mg/dL proteinuria and 1.56g total 24-hour
urine protein, 50.3KUI/L total IgE (RV 0 to 100KUI/L), 2mm/h sedimentation rate, sterile
blood cultures (two) and urine culture, and normal thyroid function and serum cortisol
levels; negative viral serology (human immunodeficiency virus (HIV) 1/2, hepatitis B and
C).</p>
      <p>Analysis through gel electrophoresis of proteins and assessment of the levels of
immunoglobulins was performed for immunological analysis. Decreased IgG and IGA levels
were observed, with 0.79 kappa/lambda free light chains ratio (1.4 to 2.7 RV), and
immunofixation showed IgG lambda-type monoclonal component and high serum levels,
185.0mg/L (5.71 to 26.30 RV). The 24-hour urinary excretion showed a significant
increase in lambda light chains (133.0mg/L; RV&lt;4.0) and Bence Jones protein positive
for lambda free light chains. It should be noted that protein electrophoresis performed
during the leak phase showed no monoclonal bands (<xref ref-type="fig" rid="f01">Figure
1</xref>), although the replicate, after solving the acute episode, showed previously
reported gammopathy (<xref ref-type="fig" rid="f02">Figure 2</xref>). The patient was
subjected to bone biopsy with description of interstitial and perivascular plasma cells,
without cytologic atypia, monotypic for lambda-chains, which accounted for 5% of the
medullary population.</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Protein electrophoresis in the acute phase, showing no alterations regarding the
gamma-globulin region.</p>
        </caption>
        <graphic xlink:href="rbti-26-04-0416-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Protein electrophoresis performed during hospitalization following the
stabilization of an acute episode, showing alterations regarding the
gamma-globulin region.</p>
        </caption>
        <graphic xlink:href="rbti-26-04-0416-g02"/>
      </fig>
      <p>The patient was discharged on the 20<sup>th</sup> day of hospitalization without
peripheral edema, with normal renal function, 3.6g/dL albumin, normal thyroid function
without levothyroxine, and maintaining treatment with aminophylline. The patient was
referred to a hematology and internal medicine consultation.</p>
      <p>The patient returned to the hospital one month after discharge, reporting blood pressure
values lower than the usual pattern. However, hypotension was not detected during the
medical observation. The patient showed swelling of the face and was admitted to the
intermediate care unit of the internal medicine department. Laboratory tests showed
normal albumin on admission (3.9g/L), which decreased to 3.36g/L 24 hours later.
Accordingly, immunoglobulin therapy was started, with regression of clinical symptoms.
The patient has maintained the monthly treatment with 2g/kg immunoglobulin for 2 days,
without relapse of the disease since then.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Several diagnoses may mimic SCLK, and the frequent causes of rapidly progressing shock
must first be excluded.</p>
      <p>The elements to be considered in the differential diagnosis of shock, contextualized
with this clinical case, are as follows: severe hypoalbuminemia, hemoconcentration, and
development of edema without evidence of fluid overload. That triad is not
characteristic of cardiogenic, septic, or anaphylactic shock or angioedema, and cardiac
dysfunction is not observed on the echocardiogram, in the clinical case. The CRP levels
were normal; the culture tests were sterile; there was no history of allergies,
urticaria, or eosinophilia; and the total IgE levels were normal.</p>
      <p>Simultaneously, we may list kidney, liver, or nutritional factors as the possible
etiology of hypoalbuminemia.</p>
      <p>No clinical signs of chronic liver disease were found. The laboratory tests showed no
alterations, especially regarding the prothrombin time, and the abdominal computed
tomography showed no changes in liver structure. Acute renal injury was observed,
although the urine protein levels were outside the nephrotic range. There was no
clinical history information available that would indicate nutritional causes for
hypoalbuminemia, the patient had a diverse diet, and the protein electrophoresis
excluded protein-losing enteropathy.</p>
      <p>There are endocrine causes that relate to shock and fluid retention in the third space,
especially hypothyroidism. However, the analytical parameters of thyroid function were
normal. Generalized edema may also be associated with Cushing&#x2019;s syndrome with secondary
hyperaldosteronism. However, the patient showed no stigmata of hypercortisolism or of
elevated serum cortisol.</p>
      <p>For this clinical case, all those differential diagnoses may be generally excluded due
to the elevated hematocrit, which is consistent with decreased effective circulating
volume.</p>
      <p>The pathophysiology of SCLK may be divided into two phases.<sup>(<xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r02" ref-type="bibr">2</xref>)</sup> The first
results from an increase in capillary permeability that favors the passage of fluid and
albumin into the extravascular space, which is manifested by generalized edema,
hemoconcentration, and hypoproteinemia. This phase is associated with distributive shock
in the most severe cases, typically attended by preservation of
consciousness.<sup>(<xref rid="r05" ref-type="bibr">5</xref>)</sup> The second
phase is characterized by vascular repletion with hypervolemia.<sup>(<xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r02" ref-type="bibr">2</xref>)</sup></p>
      <p>The etiology of SCLK is still poorly understood. However, most cases are associated with
monoclonal gammopathy, predominantly IgG kappa.<sup>(<xref rid="r06" ref-type="bibr">6</xref>)</sup> Despite studies with mixed results, many authors advocate a
direct action of IgG paraprotein, with subsequent endothelial injury and capillary
hyperpermeability.<sup>(<xref rid="r05" ref-type="bibr">5</xref>)</sup></p>
      <p>The formation of edema may result from an alteration in the function of endothelial
cells induced by cytokines<sup>(<xref rid="r07" ref-type="bibr">7</xref>)</sup> because
cases associated with interleukin-2 therapy used in the treatment of disseminated renal
cell carcinoma and melanoma<sup>(<xref rid="r08" ref-type="bibr">8</xref>)</sup> and
with interferon beta used in the treatment of multiple sclerosis<sup>(<xref rid="r09" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref>)</sup> have been reported.</p>
      <p>Given the rarity of this situation, the data available in the literature are scarce and
refer only to case series and a few observational studies.</p>
      <p>The treatment of the acute phase of SCLK is empirical and based on supportive therapy,
wherein cautious fluid resuscitation is preferred,<sup>(<xref rid="r05" ref-type="bibr">5</xref>)</sup> given the risk of compartment syndrome and respiratory failure
due to acute pulmonary edema during the repletion phase resulting from initial
aggressive fluid resuscitation.<sup>(<xref rid="r05" ref-type="bibr">5</xref>)</sup> The
next phase consists of aminergic support organ therapy with dialysis and ventilatory
support when needed.</p>
      <p>The existence of any clinical benefit from replenishing a severe deficit of albumin is
questionable because the administered albumin may be diverted into the interstitial
space due to alterations in the capillary barrier.<sup>(<xref rid="r06" ref-type="bibr">6</xref>)</sup> However, the initial treatment during the acute phase of SCLK
with crystalloid administration may not suffice to maintain adequate intravascular
volume status.<sup>(<xref rid="r06" ref-type="bibr">6</xref>)</sup> Thus, the potential
clinical benefits of a trial of volume expansion with albumin as hemodynamic stabilizer
and intravascular oncotic pressure regulator for rescue therapy should be assessed.</p>
      <p>SCLK is a potentially relapsing disease. The relapses can have different degrees of
severity, and each of them may be eventually fatal, leading to particular interest in
treatment to prevent recurrences.</p>
      <p>Treatment with beta-2 agonists, including terbutaline, and with xanthines, including
theophylline and aminophylline, reduces SCLK relapse. A possible explanation is the
decreased capillary permeability induced by histamine and bradykinin,<sup>(<xref rid="r11" ref-type="bibr">11</xref>)</sup> and the inhibition of apoptosis of
endothelial cells resulting from the increased intracellular cAMP.<sup>(<xref rid="r05" ref-type="bibr">5</xref>)</sup> Based on studies with promising results,
some authors recommend the empirical use of monthly immunoglobulins (2g/kg) for relapse
prevention in refractory cases.<sup>(<xref rid="r05" ref-type="bibr">5</xref>,<xref rid="r12" ref-type="bibr">12</xref>)</sup></p>
      <p>In our specific case, a controlled initial fluid resuscitation had to be performed,
given the risk of pulmonary and soft tissue edema with subsequent development of
compartment syndrome. Albumin was administered to preserve the intravascular oncotic
pressure, given the severe hypoalbuminemia and refractoriness to fluid resuscitation
with crystalloids. Despite subsequent progression to acute pulmonary edema and severe
lower limb edema, clinical stability was reached after 48 hours.</p>
      <p>Aminophylline was initially administered due to the triad typical of SCLK with relapsing
symptoms; however, relapse of the syndrome occurred under this treatment. Therefore, it
was decided to begin immunoglobulin therapy. No new episodes of relapse occurred for 22
months following the introduction of this experimental therapy. It should be noted that
the diagnosis of monoclonal gammopathy, which strengthens the diagnosis of SCLK, could
have been overlooked during the SCLK phase, wherein no evidence of M band was found in
the electrophoresis, most likely because of protein losses through urine.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>CONCLUSION</title>
      <p>Strong clinical suspicion, confirmation of hemoconcentration with paradoxical
hypoalbuminemia, and exclusion of other causes of shock associated with generalized
edema are necessary to diagnose systemic capillary leak syndrome.</p>
      <p>The clinical case is paradigmatic of frequent disease relapse episodes, and the
3<sup>rd</sup> relapse is a serious and potentially fatal complication. No new
relapses have been observed thus far with the monthly immunoglobulin regimen.</p>
      <p>The progression of systemic capillary leak syndrome may be lethal at an early phase of
vascular leakage due to distributive shock, and death may occur due to pulmonary edema
at a later stage of vascular repletion with hypervolemia. Knowledge of this syndrome is
important to prevent treatment that worsens the prognosis.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p><bold>Conflicts of interest:</bold> None.</p>
      </fn>
      <fn fn-type="other">
        <p><bold>Responsible editor:</bold> Rui Moreno</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clarkson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Horwith</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Luckey</surname>
              <given-names>EH</given-names>
            </name>
          </person-group>
          <article-title>Cyclical edema and shock due to increased capillary
permeability</article-title>
          <source>Trans Assoc Am Physicians</source>
          <year>1960</year>
          <volume>73</volume>
          <fpage>272</fpage>
          <lpage>282</lpage>
          <pub-id pub-id-type="pmid">13693910</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Druey</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Greipp</surname>
              <given-names>PR</given-names>
            </name>
          </person-group>
          <article-title>Narrative review: the systemic capillary leak syndrome</article-title>
          <source>Ann Intern Med</source>
          <year>2010</year>
          <volume>153</volume>
          <issue>2</issue>
          <fpage>90</fpage>
          <lpage>98</lpage>
          <pub-id pub-id-type="pmid">20643990</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gousseff</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Arnaud</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lambert</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hot</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hamidou</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Duhaut</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Papo</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Soubrier</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ruivard</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Malizia</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tieuli&#xE9;</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Rivi&#xE8;re</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ninet</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hatron</surname>
              <given-names>PY</given-names>
            </name>
            <name>
              <surname>Amoura</surname>
              <given-names>Z</given-names>
            </name>
            <collab>Capillary Leak Syndrome Registry</collab>
          </person-group>
          <article-title>The systemic capillary leak syndrome: a case series of 28 patients
from a European registry</article-title>
          <source>Ann Intern Med</source>
          <year>2011</year>
          <volume>154</volume>
          <issue>7</issue>
          <fpage>464</fpage>
          <lpage>471</lpage>
          <pub-id pub-id-type="pmid">21464348</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marks</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Shuster</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Disorders of capillary permeability</article-title>
          <source>Br J Dermatol</source>
          <year>1973</year>
          <volume>88</volume>
          <issue>6</issue>
          <fpage>619</fpage>
          <lpage>621</lpage>
          <comment>Review</comment>
          <pub-id pub-id-type="pmid">4268684</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gousseff</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Amoura</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Idiopathic capillary leak syndrome</article-title>
          <source>Rev Med Interne</source>
          <year>2009</year>
          <volume>30</volume>
          <issue>9</issue>
          <fpage>754</fpage>
          <lpage>768</lpage>
          <comment>French</comment>
          <pub-id pub-id-type="pmid">19615793</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Atkinson</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Waldmann</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Stein</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Gelfand</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Macdonald</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Heck</surname>
              <given-names>LW</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Systemic capillary leak syndrome and monoclonal IgG gammopathy:
studies in a sixth patient and a review of the literature</article-title>
          <source>Medicine (Baltimore)</source>
          <year>1977</year>
          <volume>56</volume>
          <issue>3</issue>
          <fpage>225</fpage>
          <lpage>239</lpage>
          <pub-id pub-id-type="pmid">870792</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hoffman</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Fontana</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Steurer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bollinger</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Idiopathic oedema with increased cytokine production: a pathogenetic
link?</article-title>
          <source>J Intern Med</source>
          <year>1998</year>
          <volume>244</volume>
          <issue>2</issue>
          <fpage>179</fpage>
          <lpage>182</lpage>
          <pub-id pub-id-type="pmid">10095806</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vial</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Descotes</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Clinical toxicity of interleukin-2</article-title>
          <source>Drug Saf</source>
          <year>1992</year>
          <volume>7</volume>
          <issue>6</issue>
          <fpage>417</fpage>
          <lpage>433</lpage>
          <comment>Review</comment>
          <pub-id pub-id-type="pmid">1418698</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walther</surname>
              <given-names>EU</given-names>
            </name>
            <name>
              <surname>Hohlfeld</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Multiple sclerosis: side effects of interferon beta therapy and their
management</article-title>
          <source>Neurology</source>
          <year>1999</year>
          <volume>53</volume>
          <issue>8</issue>
          <fpage>1622</fpage>
          <lpage>1627</lpage>
          <pub-id pub-id-type="pmid">10563602</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Niederwieser</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Lethal capillary leak syndrome after a single administration of
interferon beta-1b</article-title>
          <source>Neurology</source>
          <year>2000</year>
          <volume>54</volume>
          <issue>7</issue>
          <fpage>1545</fpage>
          <lpage>1546</lpage>
          <pub-id pub-id-type="pmid">10751284</pub-id>
        </element-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Svensj&#xF6;</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Adamski</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Grega</surname>
              <given-names>GJ</given-names>
            </name>
          </person-group>
          <article-title>Quantitative physiological and morphological aspects of microvascular
permeability changes induced by histamine and inhibited by
terbutaline</article-title>
          <source>Acta Physiol Scand</source>
          <year>1982</year>
          <volume>116</volume>
          <issue>3</issue>
          <fpage>265</fpage>
          <lpage>273</lpage>
          <pub-id pub-id-type="pmid">6188327</pub-id>
        </element-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gousseff</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Arnaud</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lambert</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hot</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hamidou</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Duhaut</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Papo</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Soubrier</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ruivard</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Malizia</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tieuli&#xE9;</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Rivi&#xE8;re</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ninet</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hatron</surname>
              <given-names>PY</given-names>
            </name>
            <name>
              <surname>Amoura</surname>
              <given-names>Z</given-names>
            </name>
            <collab>Capillary Leak Syndrome Registry</collab>
          </person-group>
          <article-title>The systemic capillary leak syndrome: a case series of 28 patients
from a European registry</article-title>
          <source>Ann Intern Med</source>
          <year>2011</year>
          <volume>154</volume>
          <issue>7</issue>
          <fpage>464</fpage>
          <lpage>471</lpage>
          <pub-id pub-id-type="pmid">21464348</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
